Enovis Corporation

ENOV ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $151.1M $128.1M $167.7M $392.1M $178.6M $-64.4M $4.6M $16.2M
Depreciation & Amortization $72.7M $128.8M $137.0M $174.7M $119.3M $183.4M $22.6M $16.8M
Depreciation — — — — — — — —
Amortization $39.8M $57.4M $56.8M $67.1M $41.0M $85.1M — —
Stock-Based Compensation $21.5M $19.0M $16.3M $17.6M $13.3M $9.4M $4.9M $3.1M
Net Cash from Operating Activities $218.8M $247.0M $303.8M $385.8M $362.2M $174.0M $57.2M $62.0M
Investing Activities
Capital Expenditures $68.8M $63.3M $69.9M $84.5M $71.5M $83.6M $14.8M $12.5M
Business Acquisitions $346.8M $26.0M $196.0M $948.8M $372.5M $1.86B $56.3M $28.0M
Net Cash from Investing Activities $89.9M $-82.0M $-247.0M $-1.03B $-475.0M $-1.94B $-70.0M $-40.4M
Financing Activities
Dividends Paid — — — — — $0 $0 $205.0K
Stock Repurchases $0 $20.8M $27.4M $0 $0 — — —
Net Cash from Financing Activities $-280.4M $-145.2M $-131.3M $650.0M $-45.1M $2.18B $32.7M $-8.0M
Net Change in Cash $40.3M $24.3M $-108.0M $-5.9M $-171.1M $407.3M $14.6M $10.6M
Free Cash Flow $150.0M $183.7M $233.9M $301.3M $290.7M $90.4M $42.4M $49.4M
← Newer Page 2 of 3 Older →